Patients Could Benefit From Payers Being Introduced Into Clinical Trials Earlier

AJMC July 20, 2024
Julia Bonavitacola

Doug Fulling, MA, and Andrew Cournoyer, MBA, discuss how patients could benefit from payers learning more about a new drug by joining clinical trials earlier.

Doug Fulling, MA, president of Precision AQ, and Andrew Cournoyer, MBA, senior vice president and director of the access experience team, Precision AQ, spoke with The American Journal of Managed Care^® about how introducing payers into clinical spaces earlier could benefit their patients.

This transcript has been lightly edited for clarity.

Transcript

How can patients benefit from payers being introduced into clinical trials earlier?

Doug Fulling: One of the big focuses in clinical research is to diversify the patient populations that actually participate in clinical research. And if you think about payers, they have access...

Today's Sponsors

Today's Sponsor